Global Access to Medicines: Will Canada Meet the Challenge? – Supplementary submission to the Standing Committee on Industry, Science and Technology regarding Bill C-9, An Act to amend the Patent Act and the Food and Drugs Act

The Standing Committee has asked that we provide our views regarding the “alternatives” to the right of refusal that have been put forward by other witnesses appearing before the Committee. We address several of the most important points that have been put before the Committee.

Global Access to Medicines: Will Canada Meet the Challenge? – A Submission to the Standing Committee on Industry, Science and Technology regarding Bill C-9, An Act to amend the Patent Act and the Food and Drugs Act

Bill C-9 is Canada’s legislation to implement the WTO General Council Decision of 30 August 2003. The bill, therefore, should fully reflect the flexibility that the WTO Decision creates for countries to use compulsory licensing to import cheaper, generic phramaceutical products.

Statement to the UN Commission on Human Rights re: HIV/AIDS, Sexual Orientation, Gender Identity and Non-discrimination (Item 6)

This statement first examines the connection between non-discrimination and effective responses to HIV/AIDS, and then sets out existing language by UN Treaty Bodies and Special Procedures which confirms that the right of lesbians, gays, bisexuals and transgendered people to be protected from discrimination is already established in international human rights law.

Letter to federal Industry Minister Allan Rock re: Patent Act amendments and the export of Canadian-made generic medicines

“We write to you, as representatives of Canadian civil society organizations, to request that the Government of Canada take a simple, yet significant, step to demonstrate leadership and to enhance our country’s response to the HIV/AIDS pandemic and other global health challenges: we ask that you amend Canada’s Patent Act to facilitate the export of … Read more